In Vivo CRO Market by Model Type (Rodent, Non-Rodent), by Service Offering (CRO Services, Equipment & Reagents, Animal Models & Strains, Software & Analytics), by Modality (Small & Large Molecules, RNA Therapies, Biologics), by GLP Compliance (GLP, Non-GLP), by Indication (Oncology, CNS Disorders, Autoimmune, Pain, Metabolic, and Others), and by End User (Pharmaceutical & Biotech, CROs, Hospitals, and Research Institutes) – Global Opportunity Analysis and Industry Forecast, 2025–2030.
